StockData
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31

Fortrea Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$22.42−0.07 (-0.31%)

Close on Oct 19, 2026

Market cap
$2.13B
P/E (TTM)
–
Dividend yield
–

About Fortrea

Services-Medical Laboratories, SIC 8071

Fortrea Holdings Inc. is a global contract research organization that delivers biopharmaceutical product and medical device development services. The company provides clinical pharmacology, phase I through IV clinical trial management, and specialized consulting services across more than twenty therapeutic areas, including oncology, central nervous system disorders, and metabolic diseases. Fortrea manages its business within a single reporting segment, Clinical Services, and serves pharmaceutical, biotechnology, and medical device companies ranging from small and emerging biotechs to large global pharmaceutical firms.

The company operates across approximately 100 countries, supported by a workforce of roughly 14,300 employees distributed across the Americas, Europe, the Middle East and Africa, and the Asia-Pacific region. Fortrea maintains dedicated clinical research units located in Leeds in the United Kingdom, as well as Dallas, Daytona, and Madison in the United States. Fortrea Holdings Inc. is incorporated in Delaware, and the provided text does not identify its corporate headquarters location.

Summary of the business section of Fortrea's latest annual report, written by StockData.

Company profile

Company

Legal name
Fortrea Holdings Inc.
Founded
2023
Headquarters
Durham, NC
Address
8 Moore Drive 27709
Phone
(877) 495-0816
Employees
14,300, Dec 31, 2025
Industry
Services-Medical Laboratories
Fiscal year ends
December 31
Auditor
Deloitte & Touche LLP, Raleigh, North Carolina

Stock & identifiers

Ticker
FTRE
Exchange
Nasdaq
Shares outstanding
95M, Jul 27, 2026
Public float
$448.40M, Jun 30, 2025
Filer category
Accelerated filer
SEC CIK
1965040
CUSIP
34965K107
ISIN
US34965K1079
LEI
5493000FIVFABOVCDU97
EIN
92-2796441

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Anshul ThakralChief Executive Officer, Director204,940
David Ross SmithInterim CFO, Director36,715
Thomas PikeChief Executive Officer, Director159,868
Jason Fredrick KnoblauchChief Financial Officer275
Mark A. MoraisChief Operating Officer86,419
Carrie Elizabeth RussellInterim CAO2,384
Jill G. McconnellChief Financial Officer78,416
Robert ParksChief Accounting Officer20,389
James S. HansonGeneral Counsel19,117
Machelle SandersDirector36,399
William J. SharbaughDirector–
Erin L. RussellDirector72,617
Peter M. NeupertDirector246,668
Edward A. PesickaDirector52,453
Amrit RayDirector52,453
R. Andrew EckertDirector13,636

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Peter Neupert
$1.15M$2.90M$1.65M$51$121
FY2025
Thakral
$11.58M$31.94M$1.65M$51$121
FY2025
Thomas Pike
$7.98M$3.29M$1.65M$51$121
FY2024
Thomas Pike
$1.71M-$14.71M$1.34M$55$107
FY2023
Thomas Pike
$26.32M$34.24M$3.15M$103$104

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“Our team of approximately 14,300 employees is able to conduct operations in approximately 100 countries.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jun 12, 2025ListingRegistration of securities on an exchange (Form 8-A)
May 15, 2024Late filingNotification of late filing
May 15, 2023Spin-offRegistration as a new public company (Form 10), e.g. spin-off
Apr 5, 2023Name changeName changed from Silver Spinco Inc. to Fortrea Holdings Inc.